Accession | Title | Sample type | Organism(s) | Ch | Platform | Series | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|---|
![]() |
![]() |
||||||||
GSM6576325 |
Sham_1
|
SRA | 1 | Erliang Li | Jul 01, 2024 | ||||
GSM6576326 |
Sham_2
|
SRA | 1 | Erliang Li | Jul 01, 2024 | ||||
GSM6576327 |
Mild_1
|
SRA | 1 | Erliang Li | Jul 01, 2024 | ||||
GSM6576328 |
Mild_2
|
SRA | 1 | Erliang Li | Jul 01, 2024 | ||||
GSM6576329 |
Moderate_1
|
SRA | 1 | Erliang Li | Jul 01, 2024 | ||||
GSM6576330 |
Moderate _2
|
SRA | 1 | Erliang Li | Jul 01, 2024 | ||||
GSM6576331 |
Severe_1
|
SRA | 1 | Erliang Li | Jul 01, 2024 | ||||
GSM6576332 |
Severe_2
|
SRA | 1 | Erliang Li | Jul 01, 2024 |